1991 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens

Sobas, M., Montesinos, P., Boluda, B., Bernal, T., Vellenga, E., Nomdedeu, J., Gonzalez-Campos, J., Chillon, M., Holowiecka, A., Esteve, J., Bergua, J., David Gonzalez-Sanmiguel, J., Gil-Cortes, C., Tormo, M., Salamero, O., Manso, F., Fernandez, I., de la Serna, J., Moreno, M-J., Perez-Encinas, M. & 34 others, Krsnik, I., Ribera, J-M., Escoda, L., Lowenberg, B., Angel Sanz, M., Beltran de Heredia, J. M., Hernandez, J. M., Arias, J., Ramos, F., Roman, A., de la Serna, J., Negri, S., Rayon, C., Esteve, J., Fernandez-Calvo, F. J., Diaz-Mediavilla, J., Gil, C., Tormo, M., Olave, M., Amutio, E., Pedro, C., Gorosquieta, A., Viguria, M., Zudaire, M., Molero, T., Sayas, M. J., Guardia, R., Martinez, J., de Groot, M. R., Schouten, H. C., PETHEMA Cooperative Grp, HOVON Cooperative Grp, PALG Cooperative Grp & GATLA Cooperative Grp, 21 Mar 2019, In : Leukemia & Lymphoma. 60, 4, p. 1030-1035 6 p.

Research output: Contribution to journalArticleAcademicpeer-review

Antilymphocyte globulin for matched sibling donor transplantation in patients with myelofibrosis

Robin, M., Chevret, S., Koster, L., Wolschke, C., Yakoub-Agha, I., Bourhis, J. H., Chevallier, P., Cornelissen, J. J., Remenyi, P., Maertens, J., Poire, X., Craddock, C., Socie, G., Itala-Remes, M., Schouten, H. C., Marchand, T., Passweg, J., Blaise, D., Damaj, G., Ozkurt, Z. N. & 7 others, Zuckerman, T., Cluzeau, T., Labussiere-Wallet, H., Cammenga, J., McLornan, D., Chalandon, Y. & Kroger, N., 31 May 2019, In : Haematologica-the Hematology Journal. 104, 6, p. 1230-1236 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation

Norkin, M., Shaw, B. E., Brazauskas, R., Tecca, H. R., Leather, H. L., Gea-Banacloche, J., Kamble, R. T., DeFilipp, Z., Jacobsohn, D. A., Ringden, O., Inamoto, Y., Kasow, K. A., Buchbinder, D., Shaw, P., Hematti, P., Schears, R., Badawy, S. M., Lazarus, H. M., Bhatt, N., Horn, B. & 32 others, Chhabra, S., Page, K. M., Hamilton, B., Hildebrandt, G. C., Yared, J. A., Agrawal, V., Beitinjaneh, A. M., Majhai, N., Kindwall-Keller, T., Olsson, R. F., Schoemans, H., Gale, R. P., Ganguly, S., Ahmed, I. A., Schouten, H. C., Liesveld, J. L., Khera, N., Steinberg, A., Shah, A. J., Solh, M., Marks, D. I., Rybka, W., Aljurf, M., Dietz, A. C., Gergis, U., George, B., Seo, S., Flowers, M. E. D., Battiwalla, M., Savani, B. N., Riches, M. L. & Wingard, J. R., Feb 2019, In : Biology of Blood and Marrow Transplantation. 25, 2, p. 362-368 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

Clinical significance of complex karyotype at diagnosis in pediatric and adult patients with de novo acute promyelocytic leukemia treated with ATRA and chemotherapy

Labrador, J., Luno, E., Vellenga, E., Brunet, S., Gonzalez-Campose, J., Chillon, M. C., Holowiecka, A., Esteve, J., Bergua, J., Gonzalez-Sanmiguel, J. D., Gil, C., Tormo, M., Salamero, O., Manso, F., Fernandez, I., de laSerna, J., Moreno, M-J., Perez-Encinas, M., Krsnik, I., Ribera, J-M. & 34 others, Cervera, J., Calasanz, M. J., Boluda, B., Sobas, M., Lowenberg, B., Sanz, M. A., Montesinos, P., Palmer, L., Fernandez, Ciarlo, S., Bezares, F., Rojas, F., Longoni, H., Gelemur, M., Fazio, P., Canepa, C., Saba, S., Balladares, G., Negri, P., Giunta, M., Milone, J., Prates, M., Lafalse, D., Sossa, C., Jaramillo, F., Mayer, J., Ramos, F., Martinez, J., de Groot, M. R., Schouten, H. C., PETHEMA Grp, HOVON Grp, PALG Grp & GATLA Grp, 16 Apr 2019, In : Leukemia & Lymphoma. 60, 5, p. 1146-1155 10 p.

Research output: Contribution to journalArticleAcademicpeer-review

Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation

Chhabra, S., Liu, Y., Hemmer, M. T., Costa, L., Pidala, J. A., Courie, D. R., Alousi, A. M., Majhai, N. S., Stuart, R. K., Kim, D., Ringden, O., Urbano-Ispizua, A., Saad, A., Savani, B. N., Cooper, B., Marks, D. I., Socie, G., Schouten, H. C., Schoemans, H., Abdel-Azim, H. & 26 others, Yared, J., Cahn, J-Y., Wagner, J., Antin, J. H., Verdonck, L. F., Lehmann, L., Aljurf, M. D., MacMillan, M. L., Litzow, M. R., Solh, M. M., Qayed, M., Hematti, P., Kamble, R. T., Vij, R., Hayashi, R., Gale, R. P., Martino, R., Seo, S., Hashmi, S. K., Nishihori, T., Teshima, T., Gergis, U., Inamoto, Y., Spellman, S. R., Arora, M. & Hamilton, B. K., Jan 2019, In : Biology of Blood and Marrow Transplantation. 25, 1, p. 73-85 13 p.

Research output: Contribution to journalArticleAcademicpeer-review